Shopping Cart
- Remove All
- Your shopping cart is currently empty
HLA-B*0801-bindingEBV peptide, derived from the Epstein-Barr virus (EBV) epitope FLRGRAYGL, interacts with the HLA-B*0801 molecule. This peptide is presented to CD8+ T cells via HLA-B*0801, thereby activating a specific immune response.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | HLA-B*0801-bindingEBV peptide, derived from the Epstein-Barr virus (EBV) epitope FLRGRAYGL, interacts with the HLA-B*0801 molecule. This peptide is presented to CD8+ T cells via HLA-B*0801, thereby activating a specific immune response. |
Molecular Weight | 1052.23 |
Formula | C49H77N15O11 |
Cas No. | 139143-28-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.